TQH3906 capsules

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Conditions

Plaque PsoriasisPsoriasis

Phase 2

Treatment of Moderate to Severe Plaque Psoriasis

CompletedNCT06542614

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Plaque Psoriasis

Start: 2024-08-27End: 2025-12-06Updated: 2026-01-30

Phase 3

A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis

RecruitingNCT07724366

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Psoriasis

Start: 2026-09-02End: 2028-06-01Target: 400Updated: 2026-09-09